BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Business

  Organon Declares International Women’s Day a Corporate Holiday

  The global women’s health company took another step in its initiative to encourage healthcare equality for women by declaring March 8, International Women’s Day, an annual holiday.

  February 2, 2022

   · 

  2 min read

   · 

  Claudia Beezhold
• 

  Drug Development

  Report: External Partnerships, Infectious Disease Research Drives Biopharma Innovation

  In a new “Measuring the Return from Pharmaceutical Innovation” report by Deloitte’s Center for Health Solutions, returns from R&D innovation are up by 7% across the industry.

  February 2, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Global Roundup: Australia’s Beroni Group Opens First R&D Facility in China

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  February 2, 2022

   · 

  6 min read

   · 

  Alex Keown
• 

  Drug Development

  Biomarker Test Could Unlock Personalized Medicine in Alzheimer’s Disease

  Up to 40% of AD patients were found to have Lewy Bodies in their brain after succumbing to the disease.

  February 2, 2022

   · 

  5 min read

   · 

  Hayley Shasteen
• Rabies Diagnostics Market: High prevalence of rabies worldwide is expected to drive the market

  Neglected tropical diseases have usually plagued densely populated areas with low resource availability across the globe.

  February 2, 2022

   · 

  4 min read
• Phenylketonuria Treatment Market Growth Opportunity Analysis Report

  The phenylketonuria treatment market has been experiencing the rapid growth opportunities in the upcoming years.

  February 2, 2022

   · 

  8 min read
• Next Generation Hemophilia Therapies Market: Increase in initiatives for hemophilia awareness is a key factor driving the market

  Next generation hemophilia therapies are aimed at revolutionizing the clinical outcomes and quality of life of hemophilia patients.

  February 2, 2022

   · 

  5 min read
• Vaccine Delivery Devices Market to Garner US$ 10.25 Billion by 2032 – Exclusive Fact.MR Study

  Fact.MR – A Market Research and Competitive Intelligence Provider: The vaccine delivery systems market was valued at US$ 3.81 billion in 2021, and is expected to reach US$ 4.14 billion by the end of 2022, reflecting an increase of 8.6% year over year.

  February 2, 2022

   · 

  6 min read
• Rising Prevalence of Cancer to Stimulate the Primary Cell Culture Market Growth

  Fact.MR – A Market Research and Competitive Intelligence Provider: The global primary cell culture market is expected to develop at an 11.6% CAGR from 2021 to 2031.

  February 2, 2022

   · 

  7 min read
• Biopharmaceutical Bioseparation Systems Market: Key Trends & Geographical Analysis

  Biopharmaceutical bioseparation is a process of purifying or separating a biological product or biopharmaceutical of interest such as a monoclonal antibody, protein, and cells on a large scale from a complex mixture of biomolecules.

  February 2, 2022

   · 

  5 min read